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Abstract
Objective—To determine changes in chondrocyte transcription of a range of anabolic, catabolic
and signaling genes following simultaneous treatment of cartilage with IGF-1 and ramp-and-hold
mechanical compression, and compare with effects on biosynthesis.
Methods—Explant disks of bovine calf cartilage were slowly compressed (unconfined) over 3-min
to their 1mm cut-thickness (0%-compression) or to 50%-compression with or without 300 ng/ml
IGF-1. Expression of 24 genes involved in cartilage homeostasis was measured using qPCR at 2, 8,
24, 32, 48 hours after compression ± IGF-1. Clustering analysis was used to identify groups of co-
expressed genes to further elucidate mechanistic pathways.
Results—IGF-1 alone stimulated gene expression of aggrecan and collagen II, but simultaneous
24-hour compression suppressed this effect. Compression alone upregulated expression of MMP-3,
MMP-13, ADAMTS-5 and TGF-β, an effect not reversed by simultaneous IGF-1 treatment.
Temporal changes in expression following IGF-1 treatment were generally slower than that following
compression. Clustering analysis revealed five distinct groups within which the pairings, TIMP-3
and ADAMTS-5, MMP-1 and IGF-2, and IGF-1 and Collagen II, were all robustly co-expressed,
suggesting inherent regulation and feedback in chondrocyte gene expression. While aggrecan
synthesis was transcriptionally regulated by IGF-1, inhibition of aggrecan synthesis by sustained
compression appeared post-transcriptionally regulated.
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Conclusion—Sustained compression markedly altered the effects of IGF-1 on expression of genes
involved in cartilage homeostasis, while IGF-1 was largely unable to moderate the transcriptional
effects of compression alone. The demonstrated co-expressed gene pairings suggest a balance of
anabolic and catabolic activity following simultaneous mechanical and growth factor stimuli.
Keywords
IGF-1; Chondrocyte Gene Expression; Mechanical Compression; Growth Factor treatment;
mechanobiology
Introduction
Insulin-like growth factor-1 (IGF-1, M.W. 7.6 kDa, pI = 8.5) is a potent anabolic factor capable
of endocrine and paracrine/autocrine signaling. While IGF-1 is primarily produced in the liver
and transported throughout the body via the blood stream, studies have shown that
chondrocytes produce this important growth factor, and that IGF-1 can stimulate ECM
biosynthesis by chondrocytes in native cartilage and tissue engineered constructs. The use of
growth factors as therapeutics to reverse or inhibit cartilage degradation has been an important
focus in cartilage research. The avascular and alymphatic nature of cartilage suggests the need
for local delivery, which is complicated since diffusion rates and penetrance into tissue are
affected by joint motion and cartilage structure[1-4].
Previous studies with free swelling explants in vitro have delineated certain effects of
exogenous IGF-1 on chondrocyte protein biosynthesis and gene transcription. IGF-1 can
stimulate chondrocyte synthesis of ECM in a dose dependent manner[5-10]. While culture
conditions have varied, (e.g., explants, cell-seeded gels, cell monolayers), chondrocyte
biosynthesis levels increased from 1.5- [8] to 2-6 fold over[7,10-12] control levels. IGF-1 can
also inhibit production of specific proteins such as MMP-13[13]. At the gene expression level,
type II collagen was significantly up-regulated by IGF-1[7,14-16]. Aggrecan transcripts
showed no[7,8] or slight up-regulation by 48 hours of IGF-1 treatment[16], though moderate
up-regulation (130%) after 1-3 weeks[14]. The transcription factor, Sox-9, also showed no
significant response to IGF-1[15]. Interestingly, IGF-1 transcript levels peaked at 24 hours
after exogenous IGF-1 treatment, suggesting an autocrine response[5].
Chondrocytes are highly responsive to mechanical compression at both protein and gene
transcript levels. Recent studies of cartilage deformation in vivo using combined dual
fluoroscopic and MR imaging technique with healthy human subjects showed that within 20s
of steady, full body-weight loading, contact compressive strains within ankle cartilage
increased to 24-38%, and static creep equilibrium was reached by ~50s[17]. This transient-to-
static deformation in vivo provides an important benchmark for the ranges of stresses, strains
and strain rates applied to cartilage specimens in vitro in studies of chondrocyte
mechanotransduction. Static compression of cartilage explants[9,18], chondrocyte-seeded
alginate and type I collagen gels[19,20] decreased synthesis of collagen and proteoglycans in
a dose-dependent manner. In explants, this inhibition occurred within 1-2 hours of load
application[21,22]. In contrast, static compression caused a transient increase in aggrecan and
type II collagen transcripts for 1-4 hours post-compression, followed by decreased expression
to control levels[18,20,23,24]. Fitzgerald[24] applied a ~3 min ramp compression to cartilage
explants and found time-dependent gene expression patterns during 24-hours of subsequent
static compression that depended on intracellular calcium and cyclic AMP for a range of ECM
molecules, proteinases, TIMPs, cytokines, growth and transcription factors.
Relevant to the present study, Bonassar[9] found a 2-3 fold increase in proteoglycan and protein
synthesis when cartilage explants were treated with 300 ng/ml IGF-1 at 0%-compression (cut
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thickness) for 48 hour. Under 50% static compression alone, biosynthesis decreased by 50%
compared to 0%-compressed controls. However, when 50%-compressed explants were treated
with IGF-1, biosynthesis rates significantly increased back to levels comparable to non-
compressed, non-IGF-1-treated controls. Thus, compression diminished but did not eliminate
the effects of IGF-1, and IGF-1 could up-regulate synthesis rates in statically compressed
explants. Plumb[25] reported similar trends using elderly human cartilage. Taken together,
these findings have suggested that chondrocyte biosynthetic response to simultaneous
mechanical and biochemical stimuli can occur through separate cellular pathways. However,
the corresponding changes in gene expression in response to the physiologically relevant
combinations of growth factor (IGF-1) treatment and compression have not been studied, to
our knowledge. Thus, our objectives were (1) to elucidate and compare the changes in
chondrocyte transcription of a range of anabolic, catabolic and signaling genes following
stimulation by compression alone, IGF-1 alone, or combined treatment with IGF-1 and
sustained compression in cartilage explants, and (2) to test the hypothesis that IGF-1 treatment
combined with sustained compression causes co-expression of gene groupings indicative of
attempts by chondrocytes to maintain homeostasis.
Methods
Cartilage Harvest, Compression, and Growth Factor Treatment
Cartilage-bone plugs were harvested from the patellofemoral grooves of 1-2 week old calves
(Research 87, Hopkinton, MA). Cartilage disks (1mm-thick X 3mm-diameter) were cored and
punched from the middle zone as described previously[24] and equilibrated for two days under
free-swelling conditions in serum-free medium (high-glucose Dulbecco's modified essential
medium with 10 mM Hepes Buffer, 0.1 mM nonessential amino acids, 20 μg/ml ascorbate,
100 units/ml penicillin, 100 μg/ml streptomycin, 0.25 μg/ml amphotericin B) (Sigma, St.
Louis). Five anatomically matched disks were separated for each time point (Fig. 1), and placed
in polysulfone loading chambers[24]. Each time point included four separate conditions: 8
disks each were allocated to 0%-compression (uniaxial unconfined compression to 1-mm cut-
thickness from free swelling), 50%-compression, 0%-compression + 300 ng/ml IGF-1, and
50%-compression + 300 ng/ml IGF-1, the concentration found previously to be the lowest that
maximally stimulated similar free-swelling calf cartilage explants[9].
At time zero, all chambers were slowly compressed in a ramp-and-hold fashion to 50% strain
over a 3-minute period to avoid injurious effects of high strain rates. Disks were maintained
at 50%-compression for 2,8,24,32, and 48 hours for each of the four conditions (Fig. 1). The
disks exhibited a modest increase in stress during application of slow compression, followed
by a slow (5-10 min) stress relaxation associated with the poroelastic properties of cartilage.
Thus, the five time points were chosen to capture the kinetics of gene expression associated
with both the initial transient and final equilibrium components of compression[24]. At each
time point, disks were promptly removed, flash frozen in liquid nitrogen, and stored at -80° C.
This entire experiment, using 160 disks from 1 animal (2 joints), was repeated 3 more times
(4 animals total.)
RNA Extraction and Quantization, Primer Design, and qPCR
The 8 frozen disks from each time point/condition were pulverized in a liquid nitrogen cooled
apparatus to prevent RNA degradation. RNA extraction and quantitation were performed as
previously described[26]. Forward and reverse primers for 24 relevant genes (Table 1) were
designed and qPCR was performed as described[24]. Measured threshold values (Ct) were
converted to RNA copy number according to previously calculated standard curves.
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Data Normalization and Statistical Analyses
Under each loading condition and time point, each gene RNA copy number was normalized
to the 18s housekeeping gene from that same condition and time point[24,26]. Expression
levels due to experimental error, as defined by 5σ from mean, were removed. Mixed-effect
modeling: The effects of compression and IGF-1 treatment on expression of 23 genes at each
time point were evaluated using linear mixed-effects models (R software). The mixed-effect
framework allows explicit incorporation of correlations among observations in an experimental
design via random effects, which leads to more efficient estimates[27]. Independent crossed-
random effects for animal, compression, IGF-1, time, and interactions were considered.
Likelihood ratio tests were used to assess the contribution of the random effects to the
corresponding model goodness of fit for each gene. Random effects that contributed most to
the models' goodness of fit across all genes were selected for the final mixed-effects models.
The significance of fixed effects for each gene was also evaluated by likelihood ratio test.
Restricted maximum likelihood (REML) was used to estimate the parameters of the fixed
effects and the variances of the random effects in the final models for each gene. To represent
the time course of gene expression graphically (e.g., Fig. 2), the conditions 0%-compression
+ IGF-1, 50%-compression, and 50%-compression + IGF-1 were normalized to 0%-
compression levels. Thus, gene expression values below or above 1 represent a decrease or
increase in expression, respectively, compared to 0%-compression. We note that all mixed
effects model analysis was performed on log-transformed data that were not normalized to the
0%-compression, 0-IGF-1 controls and thereby accounts for any variation of control data
across time points.
Clustering and Principle Component Analyses
In addition to measuring changes in the expression magnitude of each gene, we further explored
patterns of co-expression using principle component analysis (PCA, a tool that reveals internal
structure of the data in a way which best explains the variance in the data), and clustering
analysis performed on the 3 normalized conditions (0%-compression + IGF-1, 50%-
compression, and 50%-compression + IGF-1) and the 5 time points (2,8,24,32,48 hours) over
23 genes. This resulted in a 3×5×23 matrix which was standardized by expression amplitude
[24]. After normalization of the data using PCA, the 15-dimensional space was reordered
according to greatest dimensional variance, in which the first three detentions (principle
components) represent 80% of the variance in the data[28,29]. Once the 15 principle
components had been calculated, a k-means clustering algorithm was applied to cluster the
components into k groups. The average and variance of each projected coordinate group was
calculated to give the group centroid. Centroid vectors were formed by combining the three
main principal components weighted by their projected centroid coordinate. Uniqueness of
each group's expression patterns was evaluated by student's T-test.
Results
The expression of 24 genes (Table 1) measured at each of the five time points was compared
to controls at 0%-compression with no added IGF-1. To more easily focus on specific pathways
of interest, selected results for specific genes are reported in Fig. 2; the complete results for all
genes are given in Appendix A (Supplemental Material). The significance of the fixed effects
of IGF-1, 50% compression, time, and interaction effects for each gene are presented in Table
2.
Effects of compression alone
Consistent with previous studies[24], aggrecan and collagen II were both up-regulated at early
times and then decreased to control values (aggrecan) or below controls (collagen II) at later
times (Fig. 2G,H). Genes that were consistently up-regulated over time included MMP-3,
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MMP-13, TGF-β (Fig. 2), and ADAMTS-5, c-Fos, c-Jun, and Sox-9 (Appendix A). Peak
expression of MMP-3 by 30-fold occurred at 32 hours (Fig. 2A). ADAMTS-5 and MMP-13
increased over time, peaking at 48 hours by >6-fold and >17-fold, respectively (Fig.
2B,Appendix A). TGF-β was up-regulated 2.5-fold from 8-32 hours (Fig. 2D). Also consistent
with previous data[24], c-Fos and c-Jun were up-regulated in response to 50%-compression at
all times; c-Fos, c-Jun and Sox-9 up-regulation peaked at 8 hours (23-fold, 30-fold, and 6.8-
fold, respectively (Appendix A). Interestingly, IGF-1 was the only gene that was significantly
down-regulated by 50% compression (by 50-70%, Appendix A). Significant interaction
between 50% compression and time (Table 2) suggested that the temporal evolution of
expression of many genes behaved very differently in the presence of compression.
Effects of IGF-1 alone
As expected, treatment with 300 ng/mL IGF-1 under 0%-compression caused up-regulation
of anabolic-induced genes, aggrecan and link protein, as well as TIMP-3. Link and aggrecan
were up-regulated with time, peaking at 32 hours (4-fold and 2.5-fold respectively), and still
above control levels at 48 hours (Fig. 2F,G). These results agree with previous gene expression
data showing up-regulation of aggrecan and collagen II by 18 hrs after 100 ng/ml IGF-1
treatment of bovine articular chondrocytes seeded in monolayer[30]. Unexpectedly, collagen
II was not as dramatically up-regulated compared to a previous study[30]. IGF-1 also caused
up-regulation at three or more time points of the proteases and cytokines, MMP-13, MMP-1,
TNF-α, and IL-1β, which are thought to play catabolic/remodeling roles in cartilage. MMP-13,
TNF-α, and IL-1β peaked at 24 hours to 8-fold, 2.5-fold, and 2.75-fold, respectively, above
no-IGF-1 controls (Fig. 2B, Appendix A). MMP-1 and IGF2 were up-regulated, peaking at 32
hours (4.75-fold and 3-fold, respectively), after which expression returned to control levels
(Fig. 2I,E). As with 50% static compression, Sox-9 was up-regulated at 8 hours to a comparable
level of 6.3-fold (Appendix A). Finally, TIMP-3 and HSP90 were up-regulated at all time
points, and both displayed an initial transient peak in expression (5-fold and 3-fold,
respectively), followed by a decrease over time (Fig. 2C, Appendix A). No genes measured
were down-regulated by treatment with IGF-1 up to 48 hours.
Combined Effects of IGF-1 and compression
Simultaneous treatment with 300 ng/mL IGF-1 and 50%-compression caused significant
interaction in the expression of 15 of the 23 genes tested (Table 2), including MMP-3, MMP-13
(Fig. 2), and c-Fos, c-Jun, and HSP90 (Appendix A). MMP-3 and MMP-13 were up-regulated
to peak values of ~30-fold at 24 hours (Fig. 2A,B), while TGF-β and HSP90 were upregulated
to peak levels of ~2-4-fold at 32 hours (Fig. 2D, Appendix A). c-Fos and c-Jun were up-
regulated at all time points (Appendix A). TIMP-3 showed a slow increase of expression,
peaking at 24 hours to ~20-fold (Fig. 2C). Collagen II, IGF-2, TIMP-2, and Txnip (an oxidative
stress mediator) were down-regulated at multiple time points. IGF-2 and Txnip showed a
sustained decrease over time, reaching minima of 45% and 50% below controls by 48 hours
(Fig. 2E, Appendix A). Collagen II and TIMP-2 were steadily down-regulated to 60% and
90%, respectively, by 48 hours (Fig. 2H, Appendix A).
Expression Trends and Groupings
Using the three principle components obtained by PCA, each standardized gene was projected
in to the principle component space as visualized in Fig. 3. All 15-dimensions of each gene
were used in clustering analyses to ensure that smaller gene variations were represented in the
grouping. After dividing the genes into 2-8 clusters and visually comparing their distinctness,
5 groups appeared to be an adequate number (Fig. 3), which was further verified using
silhouette graphical scoring[31]. These 5 groups each contained 4-7 genes (Table 3): the mean
expression level is represented by a centroid (Fig. 3) and the mean expression profile is shown
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in Fig. 4. The centroids were found to be significantly separated by taking the Euclidean
distance between centroids and calculating gene-to-centroid variance[24] (Table 4).
Group-1 genes (Table 3) were substantially up-regulated for all conditions and all time points
(Fig. 4A). However, their response was particularly stimulated by 50%-compression. Group-2
genes showed early up-regulation for all conditions, followed by a return to control levels by
48 hours (Fig. 4B). In contrast, all the inflammatory cytokines grouped together (group 3) and
showed substantial up-regulation by 24 hrs after IGF-1 alone (0%-compression) (Fig. 4C).
This stimulatory effect of IGF-1 on cytokines was lessened by 50%-compression. Group-4
genes were initially up-regulated, then returned to control levels following 50%-compression
with no IGF-1, opposite time evolution following IGF-1 at 0%-compression, and no change
to combined IGF-1 plus 50%-compression (Fig. 4D). Group-5 genes showed decreasing
expression with time at 50%-compression with or without IGF-1, though compression alone
was initially stimulatory (Fig. 4E). IGF-1 alone caused minimal response.
To gain additional insight into the transcriptional responses to each treatment, all genes were
additionally clustered by their response to IGF-1 alone, 50%-compression alone, and the
combination of IGF-1 plus compression. The resulting gene groupings (Tables in
Supplementary Appendix B) can be compared with clustering of all conditions and time points
together (Table 3). Under IGF-1 alone (Appendix B.1), aggrecan, link and type II collagen
grouped together as substantially upregulated, while Txnip, the only gene significantly down-
regulated by IGF-1 treatment for multiple time points, was uniquely grouped. Clusters
associated with compression alone (Appendix B.2) isolated IL-6 in its own group as highly
non-responsive to compression. In addition, the highly up-regulated transcription factors
grouped together, while transiently up-regulated proteinases grouped separately; both these
groupings support previous reports on effects of compression alone[24]. Following combined
compression plus IGF-1 (Appendix B.3), fibronectin partitioned to a unique group as non-
responsive at all times, and the majority of proteinases also grouped together.
Taken together, we examined four different sets of clustered data: compression alone, IGF-1
alone, compression + IGF-1 (Appendix B), and all conditions and times clustered together
(Table 3, Fig. 4). Importantly, three gene-pairings were consistently observed in all these
multiple clustering approaches: MMP-1 and IGF-2; TIMP-3 and ADAMTS-5; and type II
collagen and IGF-1.
Discussion
In this study, we demonstrated that 48-hour sustained compression could markedly alter the
effects of IGF-1 on expression of groups of genes involved in cartilage homeostasis, while
IGF-1 was essentially unable to moderate certain transcriptional effects of compression alone.
Temporal changes in expression following IGF-1 treatment were generally slower than those
following compression. Our results enable comparison of the anabolic transcriptional response
caused by IGF-1 under 0%-compression with the mixed anabolic and catabolic signals
observed under IGF-1 coupled with 50%-compression. In addition, through PCA and clustering
analyses, major co-expression trends were elucidated, grouping genes into highly responsive,
non-responsive, and differentially active profiles (Fig. 4). Interestingly, aggrecan, link protein,
and type II collagen transcription responded to IGF-1 in a compression-dependent manner,
while fibronectin responded to IGF-1 in a compression-independent manner (Fig. 2F,G,H;
Table 2). The gene pairs MMP-1 and IGF-2, TIMP-3 and ADAMTS-5, and type II collagen
and IGF-1 were consistently co-expressed in most conditions, suggesting co-regulating and/
or control relationships between members of each pair.
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Effects of Compression on Transport and Intratissue concentration of IGF-1
When examining the extent and kinetics of the transcriptional responses to combined IGF-1
and compression, we note that both treatments were initiated simultaneously (Fig. 1). It is
therefore important to consider whether compression could significantly alter transport of
IGF-1 into the cartilage disks and, ultimately, the binding of IGF-1 to chondrocyte receptors.
This question is also relevant to transport processes during joint loading in vivo. In a previous
study using this explant and loading system, Bonassar[9] directly measured the transport
of 125I-IGF-1 into same-sized disks of bovine calf cartilage under 0% and 50% radially
unconfined compression. They reported a small but significant slowing of the characteristic
diffusion time of 125I-IGF-1 into the tissue, from 10.0 hrs at 0% to 12.0 hrs at 50%-compression,
and a small but significant decrease (12%) in the final intratissue concentration of IGF-1 caused
by 50% relative to 0%-compression. However, when using 300 ng/ml of IGF-1 in the medium
(as in the present study), such a small decrease in intratissue IGF-1 concentration caused little
or no effect on proteoglycan biosynthesis (via 35S-sulfate incorporation)[9]. Here, we found
that aggrecan and link protein gene expression were up-regulated by IGF-1 at 0%-compression,
but dramatically down-regulated by IGF-1 at 50%-compression (Fig. 2G,F). However, the
transcriptional effects of IGF-1 on TIMP-3 and fibronectin at 0% compression were not
substantially altered by 50%-compression (Fig. 2C,H, Appendix A). Taken together, it is
unlikely that the compression-dependence of aggrecan and link protein gene expression could
be ascribed to effects of compression on transport of IGF-1.
Kinetics of aggrecan transcription vs biosynthesis
The transcription-time course data of Fig. 2 also enable quantitative comparison of the kinetics
of gene expression versus protein synthesis in response to ±loading ±IGF-1; we focus on
aggrecan as an important example (Fig. 5). At 0%-compression, 300 ng/ml IGF-1 increased
aggrecan gene expression over the entire 2-48 hours of treatment compared to no-IGF-1
controls (Fig. 5B) and, correspondingly, increased aggrecan biosynthesis ~2-fold by 24-48
hours (Fig. 5A, adapted from[8]). Together, these data suggest that IGF-1 transcriptionally
regulates aggrecan synthesis in uncompressed cartilage. In contrast, application of 50%-
compression with no IGF-1 caused a significant decrease in aggrecan biosynthesis within the
first 2 hours of compression (Fig. 5A), and this reduction was sustained during 48 hours of
sustained compression. However, 50%-compression with no IGF-1 upregulated aggrecan gene
transcription during at least the first 8 hours of compression (Fig. 5B), followed by a return to
0%-compression/no-IGF-1control levels by 24 hours. In a separate study[32], the time constant
for such compression-induced inhibition of proteoglycan synthesis was calculated to be 40
min, again much shorter than the >8-hour period of increased aggrecan transcription. These
results support the hypothesis[9] that decreased aggrecan synthesis caused by sustained
compression with no IGF-1 is regulated by post-transcriptional machinery, e.g., possibly
related to dramatic changes in chondrocyte rough endoplasmic reticulum and Golgi organelles
caused by compression of cartilage[33].
Comparison to Previous Studies
The observation that collagen II and aggrecan were initially upregulated but subsequently
down-regulated to nearly control levels by 24-48 hrs of 50%-compression alone (Fig. 2G,H)
is consistent with the literature[18,20,23,24]. While IGF-1 caused upregulation of collagen II
expression by isolated chondrocytes from young goat (8 months)[14] and normal adult human
articular cartilage[7,15], we found only modest upregulation of collagen II by IGF-1 treatment
of explants maintained at the control 0%-compression (Fig. 2H, Table 2). These differences
may be due to cartilage age, species, and/or the response of isolated cells versus intact tissue.
Similarly, MMP-1, MMP-3, and MMP-13 expression by isolated adult human chondrocytes
was unaffected by addition of IGF-1 after 48 hours[7,15], while IGF-1 treatment of immature
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bovine explants, here, caused a substantial increase in MMP-1 and MMP-13 over 4-5 time
points (Fig. 2I,B). IGF-1 mRNA levels were maximum at 32 hours (Appendix A); similarly,
previous studies using monolayer cultures of immature equine chondrocytes cultured in 100
ng/ml IGF-1 reported peak IGF-1 mRNA levels at 24 hours within a 72-hour culture period
[5]. Sox-9 expression was significantly upregulated by IGF-1 (Appendix A), while previous
studies[15] using monolayers of adult human chondrocytes showed little change in Sox-9 at
72 hours of culture with 100 ng/mL IGF-1.
Co-Expressed Gene Pairs - TIMP-3 and ADAMTS-5
TIMPs act in a stochiometric fashion to reversibly inhibit MMPs[34]. Of the four TIMPs(1-4),
TIMP-3 is a strong inhibitor of aggrecanase-1 (ADAMTS-4) and aggrecanase-2 (ADAMTS-5),
with Ki values in the subnanomolar range[35,36]. When added exogenously to bovine nasal
and porcine cartilage, TIMP-3 inhibited aggrecanase activity induced by catabolic factors
[37]. In the present study, TIMP-3 was significantly up-regulated by exogenous IGF-1 in a
compression-independent manner (Fig. 2C). Although aggrecan can be degraded by members
of the MMP family, ADAMTS-5 was recently reported to be the primary aggrecanase
responsible for aggrecan degradation in a murine model of osteoarthritis[38]. The finding that
TIMP-3 and ADAMTS-5 expression profiles were grouped together in multiple clustering
approaches suggests a biological control of aggrecan turnover, and possibly regulation of
anabolic and catabolic factors that govern this turnover. Consistent with this hypothesis,
ADAMTS-5 and TIMP-3 were also reported to cluster together in a previous study of the
transcriptional effects of 50%-compression alone (no IGF-1) in the presence and absence of
an intracellular calcium chelator (BAPTA-AM) and an inhibitor of cyclic AMP-activated
protein kinase A (Rp-cAMP) used to identify mechanotransduction mechanisms[24].
MMP-1 and IGF-2
MMP-1 (collagenase-1) cleaves key ECM molecules including collagen II, fibronectin, and
link protein[39]. MMP-1 also plays a role in the regulation of paracrine signals through the
degradation of cytokines such as IL-1β[40]. MMP-1 can also degrade IGF binding proteins
(IGFBP-3,5) which can indirectly increase the presence of free (unbound) IGFs. IGF-1 and
IGF-2 bind IGFBP-3, the most abundant IGF binding protein in human serum[41]. IGF-2
stimulates DNA and proteoglycan synthesis by chondrocytes[42], and can act in an autocrine
fashion[43], e.g., by stimulating type-1 IGF receptor (a key receptor for IGF-1 and, with lesser
affinity, IGF-2)[44,45]. The observed co-expression of MMP-1 and IGF-2 under all clustering
approaches suggests a balance through their known anabolic and catabolic activities and,
additionally, the capability of a combined anabolic response due to the stimulatory effects of
MMP-1 degradation of IGFBPs[46]. The co-expression of MMP-1 and IGF-2 has recently
been observed in tumorigenesis (via microarray analysis)[47]: MMP-1 associated with
invasion and IGF-2 with cell proliferation. To our knowledge, this is the first observation of
such clusters of co-expression in chondrocytes subjected to exogenous IGF-1 and static
compression.
Collagen II and IGF-1
Type II collagen adds structure and strength to cartilage, and IGF-1 can elevate levels of type
II collagen synthesis and gene expression under different conditions[7,14,48]. The co-
expression of type II collagen and IGF-1 under all compression and/or IGF-1 treatments
suggests a positive feedback loop between them. Under IGF-1 treatment both are up-regulated
(Fig. 2), while compression down-regulates both, consistent with data suggesting that IGF-1
acts in an autocrine fashion[5,44]. Further studies using promoter analysis must be performed
to confirm if these pairings are co-expressed.
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The combined effects of sustained compression and IGF-1 treatment on transcription of genes
involved in ECM maintenance have been demonstrated in this study. It is possible to speculate
that growth factor treatment for cartilage repair in vivo must account for the effects of cartilage
loading on growth factor-mediated chondrocyte transcription. Ongoing studies focus on the
effects of growth factor treatment of cartilage following injurious compression that might result
from joint injury in vivo.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
A schematic of the four conditions measured. 5 disks were cored for each time point and
matched for time. IGF-1 treatment and static compression were applied at time 0, and disks
were flash frozen at 2, 8, 24, 32, and 48 hours.
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Figure 2.
Gene expression of proteinases, growth factors, and ECM molecules. 8 cartilage disks were
pooled for each time point for each experiment. All genes were normalized to 18s and plotted
relative to 0%-compression 0 IGF-1. Significance of the fixed effects from the mixed model
were calculated. § denotes a significant effect of IGF-1 on gene expression; * denotes a
significant effect of compression on gene expression. (p-values < 0.05) Mean ± SE (n=4
animals)
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Figure 3.
Standardized gene expression visualized in principle component space. Principle component
1, 2, and 3 represent 80% of the variance in the data. Genes were allocated to one of five distinct
groups by way of k-means clustering. Large solid black circles denote the centroid of the
corresponding group.
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Figure 4.
Five expression profiles represent the combination of 0%-compression 300 ng/ml of IGF-1,
50%-compression 0 ng/ml of IGF-1, and 50%-compression 300 ng/ml of IGF-1. Centroid
profiles were calculated through the average projection coordinates of genes in each group,
and transformed from principle component space through use of the calculated principle
components. Mean ± SE (n varies based on group component number)
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Figure 5.
Aggrecan protein synthesis compared to aggrecan gene expression. (A) Aggrecan protein
synthesis as measured by 35S radiolabel incorporation normalized to 0%-compression 0 IGF-1
adapted from Bonassar et al. [9]. Mean plotted, significance taken from Bonassar. (B) Aggrecan
gene expression normalized to 18s and plotted relative to 0%-compression 0 IGF-1. § denotes
a significant effect of IGF-1 on gene expression; * denotes a significant effect of compression
on gene expression; see Table 2. (p-values < 0.05) Mean ± SE (n=4 animals)
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Table 3
Gene clustering groupings. Resulted gene sorting according to extent and kinetics of expression. Specific gene
allocation and centroid coordinates when all data are clustered.
Group Genes Centroid Coordinates (PC1,PC2, PC3)
1 TGF-B, c-Fos, c-Jun, Timp-3, ADAMTS-5, MMP13, MMP3 (-2.46, 2.37, -0.33)
2 Sox-9, HSP90, Timp-1, Link (-3.10, 0.95, -0.07)
3 TNF-a, IL-1, IL-4, IL-6 (-2.78, -1.50, -0.94)
4 IGF-2, MMP1, Fibronectin, Aggrecan (-2.71, -0.24, 2.03)
5 IGF-1, Txnip, Timp-2, Collagen II (0.32, 3.21, -0.19)
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Table 4
P-value of centroid profile separation. P-values were obtained through student T-test, comparing centroid to centroid
Euclidean distance. Degrees of freedom were taken as the number of genes in each group.
P-value of Centroid
Separation Centroid 1 Centroid 2 Centroid 3 Centroid 4
Centroid 2 0.032
Centroid 3 0.017 0.034
Centroid 4 0.007 0.073 0.016
Centroid 5 0.001 0.015 0.006 0.042
Osteoarthritis Cartilage. Author manuscript; available in PMC 2010 July 1.
